Research Compound Profile
SILDEPEX SIXPEX is a pharmaceutical-grade sildenafil citrate formulation engineered for laboratory research applications examining phosphodiesterase type-5 (PDE5) inhibition mechanisms. Sildenafil citrate operates through selective competitive inhibition of the phosphodiesterase-5 enzyme, preventing cyclic guanosine monophosphate degradation in vascular smooth muscle research models. This compound represents a cornerstone tool for investigators studying nitric oxide signalling pathways and cyclic nucleotide biochemistry at Stroid UK Shop.
The mechanism involves competitive binding to the catalytic domain of phosphodiesterase-5, maintaining elevated cyclic GMP concentrations in experimental tissue preparations. Research applications encompass vascular physiology studies, smooth muscle relaxation investigations, and nitric oxide pathway modulation experiments. Academic institutions utilise this compound for understanding endothelial function, pulmonary hypertension models, and cardiovascular research protocols.
Laboratory Investigation Applications
Research teams examine SILDEPEX SIXPEX in cell culture studies investigating cyclic nucleotide signalling cascades and calcium channel modulation. Vascular biology laboratories analyse its effects on endothelial nitric oxide synthase activity and downstream signalling mediators. The compound proves valuable for studying phosphodiesterase enzyme kinetics and inhibitor selectivity profiles across different PDE isoforms. Researchers at specialised pharmaceutical research facilities investigate structure-activity relationships within the phosphodiesterase inhibitor class.
Cardiovascular research programmes utilise this compound for examining vessel reactivity responses, endothelial dysfunction models, and hypertension pathophysiology studies. Additional research focuses on pulmonary arterial pressure modulation in isolated tissue preparations and organ bath experiments. Scientists studying selective receptor modulation often compare phosphodiesterase inhibition mechanisms with other signalling pathway modulators. Research into cyclic nucleotide metabolism and peptide signalling interactions frequently incorporates this well-characterised reference compound.
Technical Specifications
| Active Compound | Sildenafil Citrate |
|---|---|
| CAS Registry | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Classification | Phosphodiesterase-5 Inhibitor |
| Storage Requirements | Room temperature, dry conditions |
| Research Grade | Laboratory standard |
Research Compliance Notice
SILDEPEX SIXPEX is manufactured exclusively for in-vitro laboratory research purposes and academic investigation protocols. This compound is not intended for human consumption, therapeutic treatment, or diagnostic applications. Research institutions must ensure appropriate laboratory safety protocols and regulatory compliance when conducting studies with this phosphodiesterase inhibitor. Investigators should maintain proper documentation of experimental procedures and disposal methods according to institutional guidelines.
